ÂÜÀòÂÒÂ×

Mr. Proehl is a Founder, Chairman, President, and CEO of Dermata Therapeutics, Inc. From January 2002 until January 2014 he was President and CEO of Santarus, Inc., where he led the sale of Santarus to Salix Pharmaceuticals for $2.6 billion. Prior to Santarus, Mr. Proehl was with Hoechst Marion Roussel, Inc. for 14 years, where he served in various capacities, including VP of Global Marketing. While at Hoechst, he was responsible for marketing products in multiple therapeutic areas, including cardiology, allergy/respiratory, immunology, and neurology. Mr. Proehl holds a B.S. in Education from State University of New York at Cortland, an M.A. in Exercise Physiology from Wake Forest University, and an M.B.A. from Rockhurst College. Mr. Proehl currently serves on the boards of two public companies, Sophiris Bio Corp, and Tenax Therapeutics, Inc.